Table 3. Relationships between clinical characteristics and coNLR-PDW.
Parameters | coNLR-PDW 0 | coNLR-PDW 1 | coNLR-PDW 2 | P |
---|---|---|---|---|
n = 68 | n = 101 | n = 37 | ||
Age | ||||
≥ 60 | 26 | 47 | 20 | 0.276 |
< 60 | 42 | 54 | 17 | |
Gender | ||||
Male | 36 | 61 | 28 | 0.074 |
Female | 32 | 40 | 9 | |
Location | ||||
Colon | 33 | 51 | 22 | 0.544 |
Rectum | 35 | 50 | 15 | |
Stage | ||||
TNM I | 17 | 15 | 5 | 0.129 |
TNM II | 22 | 37 | 8 | |
TNM III | 29 | 49 | 24 | |
Differentiation | ||||
Well | 62 | 73 | 27 | 0.009 |
Poor | 6 | 28 | 10 | |
Tumor invasion depth | ||||
T1–2 | 22 | 21 | 9 | 0.235 |
T3–4 | 46 | 80 | 28 | |
Lymph node involvement | ||||
N0 | 39 | 52 | 13 | 0.090 |
N+ | 29 | 49 | 24 | |
IVE | ||||
Absence | 7 | 29 | 16 | 0.001 |
Presence | 61 | 72 | 21 | |
Diameter | ||||
≥ 5 cm | 33 | 66 | 20 | 0.083 |
< 5 cm | 35 | 35 | 17 | |
CEA | ||||
≥ 5 ng/ml | 14 | 30 | 6 | 0.180 |
< 5 ng/ml | 54 | 71 | 31 | |
CA199 | ||||
≥ 35kU/L | 9 | 14 | 7 | 0.704 |
< 35kU/L | 59 | 87 | 30 | |
LMR | ||||
≥ 3.32 | 59 | 50 | 11 | < 0.001 |
< 3.32 | 9 | 51 | 26 | |
NLR | ||||
≥ 2.0 | 0 | 82 | 37 | < 0.001 |
< 2.0 | 68 | 19 | 0 | |
PDW | ||||
≥ 17.35% | 0 | 19 | 37 | < 0.001 |
< 17.35% | 68 | 82 | 0 | |
Adjuvant chemotherapy | ||||
Yes | 42 | 59 | 18 | 0.422 |
No | 26 | 42 | 19 |